Astudiaethau DRU Cymru - Prifysgol Betsi Cadwaladr

  • Title: A Pragmatic Randomized Trial to Evaluate the Comparative Effectiveness Between Dapagliflozin and Standard of Care in Type 2 Diabetes Patients
    Acronym: The DECIDE Study
    Recruitment Site: Bronyffynon Surgery; Felinheli and Porthaethwy Surgery
    Investigator: Dr D Jones; Dr P White
    Contact Details: 

    View Lay Summary

  • Title: An incident and high risk type 1 diabetes research cohort - After Diagnosis Diabetes REsearch Support System-2 (ADDRESS-2)
    Acronym: ADDRESS-2 (DRN 552)
    Recruitment Site: Glan Clwyd Hospital; Ysbyty Gwynedd; Ysbyty Maelor
    Investigator: Dr P Bhardwaj; Dr M Cronin; Dr P Stutchfield; Prof K Weerasinghe
    Contact Details: 

    View the Lay Summary

  • Title: Can the introduction of rapid and automatic Ankle Brachial Pressure and Pulse Volume measuring device into General Practice identify the presence or absence of Peripheral Arterial Disease in cardiovascular risk groups?
    Acronym: Primary care screening for PAD in risk groups
    Recruitment Site: Clarence Medical Centre; Connah's Quay Clinic; Felinheli & Porthaethwy Surgery; Gardden Road Surgery; Pen-y-Bont Surgery; St Mark's Dee View Surgery
    Investigator: Dr S Dobson; Dr T Downes; Dr J Lewis; Dr I Reid; Dr P White; Dr R Wright
    Contact Details: 

    View Lay Summary

  • Title: Efficacy and safety of semaglutide 1.0mg once-weekly versus liraglutide 1.2mg once-daily as add-on to 1-3 oral antidiabetic drugs (OADs) in subjects with type 2 diabetes
    Acronym: SUSTAIN-10
    Recruitment Site: Clarence Medical Centre
    Investigator: Dr S Dobson
    Contact Details: 

    View Lay Summary

  • Title: Immune cell Studies in Type 1 Diabetes
    Acronym: ISTID
    Recruitment Site: Ysbyty Maelor
    Investigator: Prof J Harvey
    Contact Details: 

    View Lay Summary

  • Title: Study of the genetics of Severe Insulin Resistance.
    Acronym: DRN079 (SIRS)
    Recruitment Site: Ysbyty Maelor
    Investigator: Prof J Harvey
    Contact Details: 

    View Lay summary

  • Title: The Genetic Basis of Severe Childhood Obesity
    Acronym: Genetics of Obesity
    Recruitment Site: Ysbyty Maelor
    Investigator: 
    Contact Details: 

    View Lay Summary

  • Title: A Randomized, Double-blind, Event-driven, Placebo-controlled, Multicenter Study of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Subjects with Type 2 Diabetes Mellitus and Diabetic Nephropathy
    Acronym: The CREDENCE Trial
    Recruitment Site: Glan Clwyd Hospital
    Investigator: 
    Contact Details: 

    View Lay Summary

  • Title: A study to evaluate the effect of a digital disease management tool in patients with type 2 diabetes mellitus
    Acronym: DIAB 5013
    Recruitment Site: Marches Medical Practice
    Investigator: Dr N Chatakondu
    Contact Details: 

    View Lay Summary

  • Title: Access to Transplantation and Transplant Outcome Measures
    Acronym: ATTOM version 1
    Recruitment Site: Glan Clwyd Hospital; Ysbyty Gwynedd; Ysbyty Maelor
    Investigator: Dr S Robertson
    Contact Details: 

    View Lay Summary

  • Title: Efficacy and safety of semaglutide 1.0mg once-weekly versus liraglutide 1.2mg once-daily as add-on to 1-3 oral antidiabetic drugs (OADs) in subjects with type 2 diabetes
    Acronym: SUSTAIN-10
    Recruitment Site: Clarence House Surgery
    Investigator: Dr S Dobson
    Contact Details: 

    View Lay Summary

  • Title: Evidence into practice: evaluating a child-centred intervention for diabetes medicine management
    Acronym: EPIC Project
    Recruitment Site: Glan Clwyd Hospital; Ysbyty Gwynedd; Ysbyty Maelor
    Investigator: 
    Contact Details: 

    View Lay Summary

  • Title: Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk
    Acronym: FOURIER
    Recruitment Site: Ysbyty Maelor
    Investigator: Prof J Harvey
    Contact Details: 

    View Lay Summary

  • Title: Randomized EValuation of the Effects of Anacetrapib through Lipid-modification. A large-scale, randomized placebo-controlled trial of the clinical effects of anacetrapib among people with established vascular disease
    Acronym: REVEAL.
    Recruitment Site: Colwyn Bay Community Hospital
    Investigator: Dr C Bellamy
    Contact Details: 

    View Lay Summary